Nirogacestat (PF-3084014) is a reversible, orally bioavailable, noncompetitive, and selective gamma-secretase inhibitor with an IC50 of 6.2 nM. Inhibition of Notch signaling by Nirogacestat while minimizing gastrointestinal toxicity presents a promising approach for research of Notch receptor-dependent cancers[1].
Molecular Weight:
489.64
Purity:
99.83
CAS Number:
[1290543-63-3]
Formula:
C27H41F2N5O
Target:
Apoptosis,gamma-secretase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
